View Older Stories View More Recent Stories

Dec 9, 2025 06:21AM Terns Pharmaceuticals (TERN) PT Raised to $54 at Mizuho
Dec 9, 2025 06:14AM Terns Pharmaceuticals (TERN) PT Raised to $60 at H.C. Wainwright
Dec 9, 2025 06:11AM Terns Pharmaceuticals Inc. (TERN) files mixed shelf
Dec 9, 2025 04:36AM BMO Capital Reiterates Outperform Rating on Terns Pharmaceuticals (TERN)
Dec 8, 2025 04:54PM Terns Pharmaceuticals (TERN) PT Raised to $58 at Oppenheimer
Dec 8, 2025 02:46PM Terns Pharmaceuticals Inc. (TERN) Halted, News Pending
Dec 8, 2025 02:41PM Terns Pharmaceuticals Inc. (TERN) halted, news pending
Dec 4, 2025 07:45AM These stocks are new additions to Mizuho's 'Americas Top Picks' list
Nov 28, 2025 06:33AM Mizuho Reiterates Outperform Rating on Terns Pharmaceuticals (TERN)
Nov 26, 2025 05:08AM Terns Pharmaceuticals (TERN) PT Raised to $35 at Citizens: Becoming Best-in-Class
Nov 19, 2025 09:31AM Terns Pharmaceuticals (TERN) PT Raised to $35 at Truist Securities
Nov 4, 2025 09:07AM Terns Pharmaceuticals (TERN) PT Raised at BMO Capital on 'Strong ASH Data'
Nov 4, 2025 07:06AM H.C. Wainwright Upgrades Terns Pharmaceuticals (TERN) to Buy
Nov 4, 2025 05:14AM Terns Pharmaceuticals (TERN) PT Raised to $28 at Truist Securities
Nov 3, 2025 02:11PM Terns Pharmaceuticals (TERN) PT Raised to $24 at Oppenheimer
Nov 3, 2025 10:19AM William Blair Upgrades Terns Pharmaceuticals (TERN) to Outperform
Nov 3, 2025 09:17AM Terns presents positive TERN-701 data at ASH meeting
Oct 23, 2025 06:49AM H.C. Wainwright Reiterates Neutral Rating on Terns Pharmaceuticals (TERN)
Oct 23, 2025 04:28AM Terns Pharmaceuticals (TERN) PT Lowered to $15 at Citizens After TERN-601 Development Stopped
Oct 22, 2025 02:21AM Terns Pharmaceuticals (TERN) PT Lowered to $17 at Oppenheimer
Oct 21, 2025 04:30PM After-hours movers: Netflix, Intuitive Surgical, DraftKings, Texas Instruments
Oct 14, 2025 04:02PM Truist Securities Starts Terns Pharmaceuticals (TERN) at Buy
Oct 8, 2025 04:09AM Citizens Reiterates Market Outperform Rating on Terns Pharmaceuticals (TERN)
Sep 17, 2025 04:37AM Barclays Starts Terns Pharmaceuticals (TERN) at Overweight
Aug 20, 2025 10:49AM Mizuho Reiterates Outperform Rating on Terns Pharmaceuticals (TERN)
Jun 23, 2025 04:08PM Terns Pharmaceuticals Inc. (TERN) Presents Positive Data from Phase 1 Study of TERN-601
Jun 17, 2025 04:11AM Citizens JMP Reiterates Market Outperform Rating on Terns Pharmaceuticals (TERN)
May 13, 2025 09:30AM Terns Pharmaceuticals (TERN) PT Lowered to $15 at BMO Capital
May 9, 2025 04:38PM Terns Pharmaceuticals, Inc. (TERN) Tops Q1 EPS by 4c
Apr 21, 2025 04:18AM Citizens JMP Reiterates Market Outperform Rating on Terns Pharmaceuticals (TERN)
Apr 15, 2025 06:20AM Mizuho Reiterates Outperform Rating on Terns Pharmaceuticals (TERN)
Mar 20, 2025 05:46PM Terns Pharmaceuticals, Inc. (TERN) Tops Q4 EPS by 6c
Mar 16, 2025 10:00AM Will Pfizer step into the obesity ring? Wolfe Research answers
Feb 25, 2025 08:06AM Terns Pharmaceuticals (TERN) Provides Program Updates
Feb 24, 2025 04:08PM Terns Pharmaceuticals Inc. (TERN) Appoints Andrew Gengos as CFO
Jan 21, 2025 02:14PM Oppenheimer Reiterates Outperform Rating on Terns Pharmaceuticals (TERN)
Dec 3, 2024 04:22PM Terns Pharmaceuticals (TERN) PT Raised to $20 at Oppenheimer
Dec 3, 2024 07:00AM Terns Pharmaceuticals Inc. (TERN) Reports Positive Early Data from Phase 1 CARDINAL Trial of TERN-701
Nov 18, 2024 04:05PM Terns Pharmaceuticals Inc. (TERN) Appoints Heather Turner to its Board
Nov 13, 2024 06:54AM Terns Pharmaceuticals (TERN) PT Raised to $7.50 at H.C. Wainwright
Oct 31, 2024 06:03AM Oppenheimer Starts Terns Pharmaceuticals (TERN) at Outperform
Sep 30, 2024 06:53AM Terns Pharmaceuticals (TERN) PT Raised to $14 at Mizuho
Sep 11, 2024 06:18AM Terns Pharmaceuticals Inc. (TERN) Prices Upsized 11.92M Share Offering at $10.50/sh
Sep 10, 2024 06:48AM Mizuho Reiterates Outperform Rating on Terns Pharmaceuticals (TERN)
Sep 9, 2024 04:01PM Terns Pharmaceuticals Inc. (TERN) Announces Proposed $125M Share Offering
Sep 9, 2024 04:00PM Terns Pharmaceuticals (TERN) PT Raised to $30 at Jefferies Following +16% Gain Today
Sep 9, 2024 08:07AM Terns Pharmaceuticals Inc. (TERN) Climbs 29% Following Trial Results with TERN-601 Once-Daily Oral GLP-1R Agonist for the Treatment of Obesity
Sep 9, 2024 07:05AM Terns Pharmaceuticals (TERN) Announces Positive Phase 1 Clinical Trial Results with TERN-601 Once-Daily Oral GLP-1R Agonist for the Treatment of Obesity
Sep 6, 2024 09:18AM TD Cowen Reiterates Buy Rating on Terns Pharmaceuticals (TERN)
Sep 6, 2024 06:26AM Mizuho Adds New Names to Top Pick List
View More Recent Stories View Older Stories